Apotea Sverige AB is a leading player in the Swedish e-commerce space, specifically focusing on the online pharmacy sector. As the country’s largest pure-online pharmacy, Apotea specializes in deliver... Apotea Sverige AB is a leading player in the Swedish e-commerce space, specifically focusing on the online pharmacy sector. As the country’s largest pure-online pharmacy, Apotea specializes in delivering a comprehensive range of health, wellness, and pharmaceutical products directly to consumers. The company’s core functions revolve around providing convenient access to medications, natural remedies, beauty products, and essential health supplies through a user-friendly digital platform. Apotea’s online-only model allows it to maintain a competitive pricing strategy while offering fast and efficient delivery services, making healthcare products more accessible across Sweden. The company significantly impacts the pharmaceutical and retail industries by pushing traditional brick-and-mortar pharmacies towards digital transformation. Founded in 2011, Apotea has been instrumental in advancing e-commerce in the pharmaceutical sector, reflecting broader consumer trends towards online shopping and home delivery services in the Swedish market.
In 2024, Apotea Sverige was subject to the Corporate Sustainability Reporting Directive (CSRD)'s requirements, which mandated the company to publish EU Taxonomy disclosures.
The company reported the eligibility and alignment of Turnover, Capital Expenditure (CAPEX) and Operating Expenditure (OPEX) with the EU Taxonomy, helping assess the extent to which its business activities align with Europe's environmental sustainability goals.
Apotea Sverige has also provided an activity-level breakdown of its EU Taxonomy disclosures. This granular reporting enhances transparency around which economic activities of Apotea Sverige are considered environmentally sustainable and contribute to at least one of the six environmental objectives defined under the EU Taxonomy framework.
Metric (tonnes)
2024
2023
2022
2021 - 2017
Total Taxonomy Aligned A1 Turnover
0000000
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
Total Taxonomy Eligible A Turnover
0000000
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
Total Taxonomy Non-Eligible B Turnover
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
Metric (tonnes)
2024
2023
2022
2021 - 2017
Total Taxonomy Aligned A1 Opex
0000000
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
Total Taxonomy Eligible A Opex
0000000
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
Total Taxonomy Non-Eligible B Opex
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
7.7 CCM/CCA - Acquisition and ownership of buildings
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
Metric (tonnes)
2024
2023
2022
2021 - 2017
Total Taxonomy Aligned A1 Capex
0000000
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
Total Taxonomy Eligible A Capex
0000000
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
Total Taxonomy Non-Eligible B Capex
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
Limited Data Preview
You are viewing a limited preview of Apotea Sverige’s EU Taxonomy dataset. The full dataset, available for download, includes eligibility and alignment metrics for turnover, CAPEX, and OPEX across all EU Taxonomy categories (A1, A2, A, B, and A+B), at both aggregate and activity level, with historical coverage back to undefined.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Used by 1,000+ teams in finance, climate, and research
Verified Sources Behind Apotea Sverige’s EU Taxonomy Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Apotea Sverige’s data sources below and access millions more through our Disclosure Search.
a. Apotea Sverige's Annual Report 2024
Insights into Apotea Sverige's Revenues from Sustainable Activities
In 2024, Apotea Sverige reported EU Taxonomy-eligible revenues of SEK 0, representing 0% of its total turnover. Of this amount, SEK 0 of Apotea Sverige's revenues was classified as EU Taxonomy-aligned, indicating that 0% of the revenue-generating activities undertaken by the company substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).a
Insights into Apotea Sverige's CAPEX from Sustainable Activities
In 2024, Apotea Sverige reported EU Taxonomy-eligible CAPEX of SEK 172.00 million,representing 98% of its total CAPEX. Of this amount, SEK 0 of Apotea Sverige's CAPEX was classified as EU Taxonomy-aligned, indicating that 0% of the company's investments were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).a
Insights into Apotea Sverige's OPEX from Sustainable Activities
In 2024, Apotea Sverige reported EU Taxonomy-eligible OPEX of SEK 12.50 million,representing 90% of its total operating expenses (OPEX). Of this amount, SEK 1.60 million of Apotea Sverige's OPEX was classified as EU Taxonomy-aligned, indicating that 12% of the company's operating expenses were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).a
How much of Apotea Sverige's operational expenditure (OPEX) is eligible under the EU Taxonomy?
In 2024, Apotea Sverige reported that SEK 12.50 million of its operational expenditure (OPEX) was eligible under the EU Taxonomy, representing 90% of the company's total OPEX. Of this amount, SEK 1.60 million (12% of total OPEX) was classified as Taxonomy-aligned. This means that 78% of Apotea Sverige's OPEX is eligible but not aligned, indicating that these expenditures either did not meet the technical screening criteria, failed to comply with the Do No Significant Harm (DNSH) requirements, or lacked evidence of meeting the Minimum Safeguards (MSS).a
How much of Apotea Sverige's eligible OPEX is aligned with the EU Taxonomy?
In 2024, Apotea Sverige reported that SEK 1.60 million of its OPEX was aligned under the EU Taxonomy, representing 12% of its total operational expenditure.a
This moderate level of alignment indicates that Apotea Sverige is beginning to shift operational priorities toward greener practices, with room for deeper integration.
Apotea Sverige's Eligibility & Alignment Overview
Apotea Sverige's Contribution to Environmental Objectives
Total Taxonomy Aligned A1 Opex
Total Taxonomy Eligible but Not Aligned A2 Opex
How is Apotea Sverige's taxonomy-aligned OPEX distributed across the EU environmental objectives?
In 2024, Apotea Sverige reported that its taxonomy-aligned operational expenditure (OPEX) was distributed across the following EU environmental objectivesa:
Climate Change Mitigation: 12%
Climate Change Adaptation: 0%
Sustainable Use and Protection of Water and Marine Resources: 0%
Transition to a Circular Economy: 0%
Pollution Prevention and Control: 0%
Protection and restoration of biodiversity and ecosystems: 0%
How much of Apotea Sverige's operational budget supports climate-related solutions?
In 2024, Apotea Sverige allocated SEK 1.67 million of its OPEX to activities contributing to the EU Taxonomy's climate-related objectives (Climate Change Mitigation and Climate Change Adaptation). This represented 12% of the company's total OPEX,indicating that Apotea Sverigeis moderately integrating climate considerations into its ongoing operations, with potential to scale up climate-aligned spending.a
Want Full Access to Apotea Sverige's EU Taxonomy Dataset?